These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31602763)

  • 1. Proton-pump inhibitor overuse: a cautionary tale in misguided benefit.
    Nath K; Reyaldeen R; Palamuthusingam D
    Intern Med J; 2019 Oct; 49(10):1337. PubMed ID: 31602763
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor.
    Harewood GC; Gostout CJ
    Gastrointest Endosc; 2003 Oct; 58(4):493-9. PubMed ID: 14520279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
    Enns RA; Gagnon YM; Rioux KP; Levy AR
    Aliment Pharmacol Ther; 2003 Jan; 17(2):225-33. PubMed ID: 12534407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questions.
    Devlin JW; Welage LS
    Crit Care Med; 2004 Jun; 32(6):1415-6. PubMed ID: 15187531
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonulcer dyspepsia and proton pump inhibitors.
    Waldum HL; Martinsen TC; Brenna E
    Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
    [No Abstract]   [Full Text] [Related]  

  • 7. Are higher doses of proton pump inhibitors better in acute peptic bleeding?
    Villalón A; Olmos R; Rada G
    Medwave; 2016 Jun; 16 Suppl 2():e6476. PubMed ID: 27390875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting the cost of proton pump inhibitors.
    Moayyedi P
    Gut; 2001 Oct; 49(4):462-3. PubMed ID: 11559638
    [No Abstract]   [Full Text] [Related]  

  • 10. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users.
    Katz MH
    Arch Intern Med; 2010 May; 170(9):747-8. PubMed ID: 20458079
    [No Abstract]   [Full Text] [Related]  

  • 11. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy?
    Barkun AN
    Gastrointest Endosc; 2008 Jun; 67(7):1064-6. PubMed ID: 18513549
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-pump inhibitors in acid-related diseases.
    Berardi RR; Welage LS
    Am J Health Syst Pharm; 1998 Nov; 55(21):2289-98. PubMed ID: 9825880
    [No Abstract]   [Full Text] [Related]  

  • 14. Overuse of proton pump inhibitors and its consequences.
    Kazberuk M; Brzósko S; Hryszko T; Naumnik B
    Postepy Hig Med Dosw (Online); 2016 Oct; 70(0):1112-1116. PubMed ID: 27892894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?
    Corleto VD; Annibale B; Gibril F; Angeletti S; Serrano J; Venzon DJ; Delle Fave G; Jensen RT
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1555-61. PubMed ID: 11563994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
    Peterson K; Bjorkman DJ
    Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents.
    Cameron C; VAN Zanten SV; Skedgel C; Flowerdew G; Moayyedi P; Sketris I
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1354-64. PubMed ID: 20331582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs.
    Klok RM; Brouwers JR; Van den Berg PB; De Jong-Van den Berg LT; Tolley K; Postma MJ
    Aliment Pharmacol Ther; 2002 May; 16(5):1033-4. PubMed ID: 11966514
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
    Dubois RW; Melmed GY; Henning JM; Laine L
    Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.